Last quarter (Q3 2023), Rhythm Pharmaceuticals's total revenue was $22.50M, an increase of 425.30% from the same quarter last year. In Q3, Rhythm Pharmaceuticals's net income was $-44.16M. See Rhythm Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 41.73M	$ 23.64M	$ 3.15M	$ 0.00	$ 0.00	$ 0.00
Cost of Revenue	$ 7.10M	$ 2.13M	$ -599.00K	$ 0.00	-	-
Gross Profit	$ 34.63M	$ 21.50M	$ -599.00K	$ 0.00	-	-
Operating Expense	$ 240.08M	$ 200.66M	$ 172.61M	$ 136.57M	$ 146.00M	$ 78.42M
Operating Income	$ -205.45M	$ -179.16M	$ -173.21M	$ -136.57M	$ -146.00M	$ -78.42M
Net Non Operating Interest Income Expense	$ -2.82M	$ -5.20M	$ 447.00K	$ 2.58M	$ 5.27M	$ 4.35M
Other Income Expense	$ -22.80M	$ -3.24M	$ -103.15M	-	-	-
Pretax Income	$ -185.47M	$ -181.12M	$ -69.61M	$ -134.00M	$ -140.73M	$ -74.06M
Tax Provision	$ 368.00K	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -185.84M	$ -181.12M	$ -69.61M	$ -134.00M	$ -140.73M	$ -74.06M
Basic EPS	$ -3.24	$ -3.47	$ -1.40	$ -3.04	$ -3.86	$ -2.39
Diluted EPS	$ -3.24	$ -3.47	$ -1.40	$ -3.04	$ -3.86	$ -2.39
Basic Average Shares	$ 223.57M	$ 52.12M	$ 49.60M	$ 44.13M	$ 36.42M	$ 31.00M
Diluted Average Shares	$ 223.57M	$ 52.12M	$ 49.60M	$ 44.13M	$ 36.42M	$ 31.00M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 247.18M	$ 202.79M	$ 172.01M	$ 136.57M	$ 146.00M	$ 78.42M
Net Income From Continuing And Discontinued Operation	$ -185.84M	$ -181.12M	$ -69.61M	$ -134.00M	$ -140.73M	$ -74.06M
Normalized Income	$ -71.49M	$ -141.69M	-	$ -134.00M	$ -140.73M	$ -74.06M
Interest Expense	-	-	-	-	-	-
EBIT	$ -179.43M	$ -175.92M	$ -70.06M	$ -136.57M	$ -146.00M	$ -78.42M
EBITDA	$ -125.92M	$ -168.86M	$ -68.90M	$ -135.88M	$ -145.17M	$ -77.97M

Currency in USD

Rhythm Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing